Arkolith/Insider Trading/CADL/Form 4

Tyagarajan Seshu

Chief Technology OfficerCandel Therapeutics, Inc. (CADL) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$70K
Net Open-Market Flow
-$70K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Sell(S)7K$10.02$70K84K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001923794-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML